Recent advances in peanut allergy
Recent advances in peanut allergy
Peanut remains preeminent as the food allergen most associated with severe and fatal allergic reactions. Reactions are frequent despite patients' best efforts to avoid peanut. In the future, better information sharing and communication between families and both schools and restaurants may lead to a decrease in the rate of severe reactions induced by exposure to peanut outside the home. Reaction severity may increase over time but up to 25% of young peanut allergic individuals may outgrow their peanut allergy. Personalized care plans and education programmes may have an impact on avoidance of peanut and on the appropriate responses of caregivers. Peanut's allergenicity may be affected by the method of cooking, with roasted peanuts appearing more allergenic than boiled or fried peanuts. Immunotherapy with modified peanut allergens and DNA based vaccines may soon move from animal studies to clinical trials.
227-231
Hourihane, Jonathan O'B.
3f506898-1e14-4bbe-a142-8dab0e14a561
2002
Hourihane, Jonathan O'B.
3f506898-1e14-4bbe-a142-8dab0e14a561
Hourihane, Jonathan O'B.
(2002)
Recent advances in peanut allergy.
Current Opinion in Allergy and Clinical Immunology, 2 (3), .
Abstract
Peanut remains preeminent as the food allergen most associated with severe and fatal allergic reactions. Reactions are frequent despite patients' best efforts to avoid peanut. In the future, better information sharing and communication between families and both schools and restaurants may lead to a decrease in the rate of severe reactions induced by exposure to peanut outside the home. Reaction severity may increase over time but up to 25% of young peanut allergic individuals may outgrow their peanut allergy. Personalized care plans and education programmes may have an impact on avoidance of peanut and on the appropriate responses of caregivers. Peanut's allergenicity may be affected by the method of cooking, with roasted peanuts appearing more allergenic than boiled or fried peanuts. Immunotherapy with modified peanut allergens and DNA based vaccines may soon move from animal studies to clinical trials.
This record has no associated files available for download.
More information
Published date: 2002
Identifiers
Local EPrints ID: 27148
URI: http://eprints.soton.ac.uk/id/eprint/27148
ISSN: 1528-4050
PURE UUID: d3272f7d-1108-48dd-a43f-236b1b863315
Catalogue record
Date deposited: 26 Apr 2006
Last modified: 22 Jul 2022 20:37
Export record
Contributors
Author:
Jonathan O'B. Hourihane
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics